Literature DB >> 18845297

Predictors of persistent detrusor overactivity after transvaginal sling procedures.

Tondalaya L Gamble1, Sylvia M Botros, Jennifer L Beaumont, Roger P Goldberg, Jay-James R Miller, Oyinlolu Adeyanju, Peter K Sand.   

Abstract

OBJECTIVE: Determine predictors of persistent postoperative detrusor overactivity and urge urinary incontinence after sling procedures for stress urinary incontinence STUDY
DESIGN: Three hundred five women with mixed urinary incontinence underwent sling procedures for stress urinary incontinence. Risk factors for persistent detrusor overactivity and urge urinary incontinence were examined using logistic regression models.
RESULTS: Women (31.5%) who had postoperative resolution of detrusor overactivity. Transobturator slings had the lowest rate of persistent detrusor overactivity (53%), followed by retropubic (SPARC = 66%; TVT = 64%) and bladder neck slings (86%). Predictors for persistent detrusor overactivity included age (odds ratio [OR], 1.38; P = .001), prior hysterectomy (OR, 1.95; P = .012), paravaginal repair (OR, 0.46; P = .015), nocturia (OR, 1.91; P = .013), maximum cystometric capacity (OR, 0.79; P < .001), detrusor overactivity volume (OR, 0.83; P = .006), urethral closure pressure (OR, 0.83; P < .001), and maximum urinary flow rate (OR, 0.77; P = .014). Persistent urge urinary incontinence was predicted by sling type (P < .001).
CONCLUSION: When treating women with mixed urinary incontinence, age, nocturia, maximum cystometric capacity, and choice of sling procedure impact persistence of detrusor overactivity and urge urinary incontinence.

Entities:  

Mesh:

Year:  2008        PMID: 18845297     DOI: 10.1016/j.ajog.2008.07.059

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  26 in total

1.  Detrusor overactivity leak point pressure in women with urgency incontinence.

Authors:  Ariana L Smith; William I Jaffe; Mary Wang; Alan J Wein
Journal:  Int Urogynecol J       Date:  2011-10-19       Impact factor: 2.894

Review 2.  Management of patients with stress urinary incontinence after failed midurethral sling.

Authors:  Alex Kavanagh; May Sanaee; Kevin V Carlson; Gregory G Bailly
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

Review 3.  Practical use of the new American Urological Association adult urodynamics guidelines.

Authors:  Bhavin N Patel; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 4.  Overactive bladder and mixed incontinence.

Authors:  Sunshine Murray; Gary E Lemack
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

5.  Urogynecological conditions associated with overactive bladder symptoms in women.

Authors:  James C Forde; Jonathan L Davila; Brian K Marks; Matthew Epstein; Johnson F Tsui; Jeffrey P Weiss; Jerry G Blaivas
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

Review 6.  Mixed urinary incontinence: international urogynecological association research and development committee opinion.

Authors:  Dorothy Kammerer-Doak; Diaa E E Rizk; Olanrewaju Sorinola; Wael Agur; Sharif Ismail; Tony Bazi
Journal:  Int Urogynecol J       Date:  2014-08-05       Impact factor: 2.894

7.  Biomaterials in urinary incontinence and treatment of their complications.

Authors:  Philippa Sangster; Roland Morley
Journal:  Indian J Urol       Date:  2010-04

8.  Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery.

Authors:  Ching-Chung Liang; Wu-Chiao Hsieh; LuLu Huang
Journal:  Int Urogynecol J       Date:  2016-09-27       Impact factor: 2.894

9.  The Effects of Suburethral Tape on the Symptoms of Overactive Bladder.

Authors:  G Hensel; M Koštál; J Göbel
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-01-21       Impact factor: 2.915

10.  When to perform urodynamics before mid-urethral sling surgery for female stress urinary incontinence?

Authors:  R Marijn Houwert; Jan Paul W R Roovers; Pieter L Venema; Hein W Bruinse; Marcel G W Dijkgraaf; Harry A M Vervest
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.